Sort   by:  
 Page size 
The inability of determining direct molecular targets of metal-based therapeutic agents beyond the platinum class is one of the major bottlenecks in their development. Here, we employ an integrated chemical proteomics and response profiling approach to identify and validate plestatins, based on an o...
ORGANISM(S): Homo sapiens (Human) 
2017-06-02 | PXD005389 | Pride
The inability of determining direct molecular targets of metal-based therapeutic agents beyond the platinum class is one of the major bottlenecks in their development. Here, we employ an integrated chemical proteomics and response profiling approach to identify and validate plestatins, based on an o...
ORGANISM(S): Homo sapiens (Human) 
2022-03-01 | PXD005377 | Pride
The inability of determining direct molecular targets of metal-based therapeutic agents beyond the platinum class is one of the major bottlenecks in their development. Here, we employ an integrated chemical proteomics and response profiling approach to identify and validate plestatins, based on an o...
ORGANISM(S): Homo sapiens (Human) 
2022-03-01 | PXD005387 | Pride
The inability of determining direct molecular targets of metal-based therapeutic agents beyond the platinum class is one of the major bottlenecks in their development. Here, we employ an integrated chemical proteomics and response profiling approach to identify and validate plestatins, based on an o...
ORGANISM(S): Homo sapiens (Human) 
2022-03-01 | PXD005378 | Pride
The inability of determining direct molecular targets of metal-based therapeutic agents beyond the platinum class is one of the major bottlenecks in their development. Here, we employ an integrated chemical proteomics and response profiling approach to identify and validate plestatins, based on an o...
ORGANISM(S): Homo sapiens (Human) 
2022-03-01 | PXD005388 | Pride
The inability of determining direct molecular targets of metal-based therapeutic agents beyond the platinum class is one of the major bottlenecks in their development. Here, we employ an integrated chemical proteomics and response profiling approach to identify and validate plestatins, based on an o...
ORGANISM(S): Homo sapiens (Human) 
2022-03-01 | PXD005386 | Pride
The inability of determining direct molecular targets of metal-based therapeutic agents beyond the platinum class is one of the major bottlenecks in their development. Here, we employ an integrated chemical proteomics and response profiling approach to identify and validate plestatins, based on an o...
ORGANISM(S): Homo sapiens (Human) 
2022-03-01 | PXD010318 | Pride
The inability of determining direct molecular targets of metal-based therapeutic agents beyond the platinum class is one of the major bottlenecks in their development. Here, we employ an integrated chemical proteomics and response profiling approach to identify and validate plestatins, based on an o...
ORGANISM(S): Homo sapiens (Human) 
2022-03-01 | PXD010319 | Pride
The remarkable plasticity of Schwann cells (SCs) is essential for nerve regeneration but also contributes to neuropathies and cancer progression. It has not yet been investigated whether the adaptive potential of SCs is manifested in stromal, tumor associated SCs characteristically found within a be...
ORGANISM(S): Homo sapiens (Human) 
2021-01-04 | PXD022217 | Pride
The remarkable plasticity of Schwann cells (SCs) is essential for nerve regeneration but also contributes to neuropathies and cancer progression. It has not yet been investigated whether the adaptive potential of SCs is manifested in stromal, tumor associated SCs characteristically found within a be...
ORGANISM(S): Homo sapiens (Human) 
2021-01-13 | PXD018267 | Pride
Sort   by:  
 Page size